KOREA ARLICO PHARM CO.,LTD. · 알리코제약(주)
Last · KOSDAQ₩4730.00+2365.00 (+100.00%)stale · yahoo · 19621h ago
Market cap——
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
₩2150.00₩5760.00
Volume—session
| Revenue | ₩199.1B |
|---|---|
| Operating income | ₩-1.8B |
| Net income | ₩-1.6B |
| Free cash flow | ₩12.2B |
| Operating margin | -0.9% |
| Net margin | -0.8% |
| Return on equity | -2.1% |
| Period | TTM 2026-03-31 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2025-03-20
- Operating Cf Burn
- Cash Runway Low
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~1.8 years
Documents
FormReporting forFiledFlags